King, CorePharma Settle Skelaxin Suit
King Pharmaceuticals Inc. has dropped one of the infringement cases concerning its muscle relaxant Skelaxin, agreeing to grant a patent license allowing the defendant, CorePharma LLC, to manufacture a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article